Anand K. Singh

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance”.

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506051

N/A

0.300DataRank · unranked

4 citations

Alvin Shi, Ming Tang, Marcus Ho, Christopher Terranova, Kyriaki Galani +36 more

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Cell Reports(2020)10.1016/j.celrep.2020.108293

N/A

0DataRank · unranked

70 citations

Emily Z. Keung, Ming Tang, Yan Liang, Hunain Alam, Guangchun Han +27 more

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

Cell Reports(2021)10.1016/j.celrep.2021.109410

N/A

0DataRank · unranked

31 citations

Ming Tang, Mayinuer Maitituoheti, Ayush T. Raman, Archit K. Ghosh, Jonathan E. Schulz +21 more

Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma

Neuro-Oncology(2023)10.1093/neuonc/noad155

N/A

0DataRank · unranked

40 citations

Carla Danussi, Sharvari Dharmaiah, W. Evan Johnson, Anand K. Singh, Kunal Rai +3 more

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML

Science Translational Medicine(2024)10.1126/scitranslmed.adp0004

N/A

0DataRank · unranked

31 citations

Anand K. Singh, Rafet Başar, Nadima Uprety, Ye Li, Huihui Fan +45 more

Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1166

N/A

0DataRank · unranked

19 citations

Ajay Kumar Saw, Van K. Morris, Stefania Napolitano, Christopher A. Bristow, Sanjana Srinivasan +11 more

Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer

Cell chemical biology(2024)10.1016/j.chembiol.2024.09.004

N/A

0DataRank · unranked

17 citations

Nicholas Blazanin, Yuanxin Xi, Yanyan Han, Md Qudratullah, Xiaobing Liang +8 more

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.23.689992

N/A

0DataRank · unranked

0 citations

Anand K. Singh, Yingda Jiang, Zheng Zhao, Davis R. Ingram, Khalida Wani +28 more